Laminopathies: Lipodystrophies, insulin resistance, syndromes of accelerated ageing... and others;Les laminopathies: Lipodystrophies, insulino-résistance, syndromes de vieillissement accéléré... et les autres

Annales d'Endocrinologie

Volumn 66, Issue 3, 2005, Pages 270-278

  Vigouroux, C ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL TENON   (France)

Author keywords

Insulino r sistance; Lamines de type A; Laminopathies; Lipo dystrophies; Vieillissement acc l r

Indexed keywords

LAMIN A; MUTANT PROTEIN;

ADIPOSE TISSUE; AGING; ATHEROSCLEROSIS; CELL NUCLEUS; CONFERENCE PAPER; DYSLIPIDEMIA; EMERY DREIFUSS MUSCULAR DYSTROPHY; FATTY LIVER; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INSULIN RESISTANCE; LIPODYSTROPHY; METABOLIC SYNDROME X; PATHOGENESIS; PROGERIA; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TISSUE SPECIFICITY;

EID: 18944366265     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(05)81761-5     Document Type: Conference Paper

References (61)

1. Agarwal AK, Fryns JP, Auchus RJ, et al. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 2003 ; 12 : 1995-2001.
2. Al-Shali KZ, Hegele RA. Laminopathies and Atherosclerosis. Arterioscler Thromb Vasc Biol 2004 ; 24 : 1-5.
3. Araujo-Vilar D, Loidi L, Dominguez F, et al. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm Metab Res 2003 ; 35 : 29-35.
4. Becane HM, Bonne G, Varnous S, et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000 ; 23 : 1661-6.
5. Benedetti S, Previtali E, Toniolo D, et al. Dominant lamin A/C gene mutations can be associated with muscular dystrophy and peripheral neuropathy. Journal of the Peripheral Nervous System 2004 ; 9 : 113.
6. Bergo MO, Gavino B, Ross J, et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A 2002 ; 99 : 13049-54.
7. Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994 ; 8 : 323-7.
8. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999 ; 21 : 285-8.
9. Bonne G, Mercuri E, Muchir A, et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000 ; 48 : 170-80.
10. Brodsky GL, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000 ; 101 : 473-6.
11. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000 ; 9 : 109-12.
12. Caux F, Dubosclard E, Lascols O, et al. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 2003 ; 88 : 1006-113.
13. Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord 2003 ; 13 : 60-7.
14. Chen L, Lee L, Kudlow BA, et al. LMNA mutations in atypical Werner's syndrome. Lancet 2003 ; 362 : 440-5.
15. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 2004 ; 41 : 304-8.
16. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003 ; 300 : 2055.
17. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002 ; 70 : 726-36.
18. Dhe-Paganon S, Werner ED, Chi YI, et al. Structure of the globular tail of nuclear lamin. J Biol Chem 2002 ; 277 : 17381-4.
19. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003 ; 423 : 293-8.
20. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999 ; 341 : 1715-24.
21. Favreau C, Higuet D, Courvalin JC, et al. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 2004 ; 24 : 1481-92.
22. Favreau C, Dubosclard E, Ostlund C, et al. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res 2003 ; 282 : 14-23.
23. Fong LG, Ng JK, Meta M, et al. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci U S A 2004 ; 101 : 18111-6.
24. Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 2000 ; 85 : 1776-82.
25. Garg A, Speckman RA, Bowcock AM. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med 2002 ; 112 : 549-55.
26. Garg A, Vinaitheerthan M, Weatherall PT, et al. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin A/C gene. J Clin Endocrinol Metab 2001 ; 86 : 59-65.
27. Goizet C, Yaou RB, Demay L, et al. A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J Med Genet 2004 ; 41 : e29.
28. Goldman RD, Shumaker DK, Erdos MR, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 2004 ; 101 : 8963-8.
29. Haque WA, Shimomura I, Matsuzawa Y, et al. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002 ; 87 : 2395.
30. Hegele RA. Premature atherosclerosis associated with monogenic insulin resistance. Circulation 2001 ; 103 : 2225-9.
31. Hegele RA, Anderson CM, Wang J, et al. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res 2000 ; 10 : 652-8.
32. Hegele RA, Kraw ME, Ban MR, et al. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 2003 ; 23 : 111-6.
33. Hutchison CJ, Worman HJ. A-type lamins: guardians of the soma? Nat Cell Biol 2004 ; 6 : 1062-7.
34. Johnson BR, Nitta RT, Frock RL, et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A 2004 ; 101 : 9677-82.
35. Kirschner J, Brune T, Wehnert M, et al. p.S143F mutation in lamin A/C: A new phenotype combining myopathy and progeria. Ann Neurol 2005 ; 57 : 148-51.
36. Krimm I, Ostlund C, Gilquin B, et al. The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure (Camb) 2002 ; 10 : 811-23.
37. Lammerding J, Schulze PC, Takahashi T, et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotrans-duction. J Clin Invest 2004 ; 113 : 370-8.
38. Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002 ; 11 : 769-77.
39. Mercuri E, Poppe M, Quinlivan R, et al. Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. Arch Neurol 2004 ; 61 : 690-4.
40. Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000 ; 9 : 1453-9.
41. Navarro CL, De Sandre-Giovannoli A, Bernard R, et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 2004 ; 13 : 2493-503.
42. Nikolova V, Leimena C, McMahon AC, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004 ; 113 : 357-69.
43. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 2002 ; 71 : 426-31.
44. Pendas AM, Zhou Z, Cadinanos J, et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 2002 ; 31 : 94-9.
45. Plasilova M, Chattopadhyay C, Pal P, et al. Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet 2004 ; 41 : 609-14.
46. Savage DB, McFarlane I, Barroso I, et al. Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 2004 ; 47 : 753-6.
47. Shackleton S, Lloyd DJ, Jackson SN, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000 ; 24 : 153-6.
48. Simha V, Agarwal AK, Oral EA, et al. Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy. J Clin Endocrinol Metab 2003 ; 88 : 2821-4.
49. Stierle V, Couprie J, Ostlund C, et al. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 2003 ; 42 : 4819-28.
50. Stuurman N, Heins S, Aebi U. Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 1998 ; 122 : 42-66.
51. Sullivan T, Escalante-Alcalde D, Bhatt H, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999 ; 147 : 913-20.
52. Tazir M, Azzedine H, Assami S, et al. Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C. Brain 2004 ; 127 : 154-63.
53. van Berlo JH, Duboc D, Pinto YM. Often seen but rarely recognised: cardiac complications of lamin A/C mutations. Eur Heart J 2004 ; 25 : 812-4.
54. van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005 ; 83 : 79-83.
55. van der Kooi AJ, Bonne G, Eymard B, et al. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 2002 ; 59 : 620-3.
56. Vantyghem MC, Pigny P, Maurage CA, et al. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J Clin Endocrinol Metab 2004 ; 89 : 5337-46.
57. Vigouroux C, Auclair M, Dubosclard E, et al. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci 2001 ; 114: 4459-68.
58. Vigouroux C, Magré J, Vantyghem MC, et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 2000 ; 49 : 1958-62.
59. Worman HJ, Courvalin JC. How do mutations in lamins A and C cause disease? J Clin Invest 2004 ; 113 : 349-51.
60. Young J, Morbois-Trabut L, Couzinet B, et al. Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes 2005; sous presse.
61. Zastrow MS, Vlcek S, Wilson KL. Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 2004 ; 117 : 979-87.